An independent two-stage DCF analysis by a frontier AI model.
Westmount Research. "HCA Healthcare (HCA) Intrinsic Value: A DCF Analysis." westmountfundamentals.com, March 19, 2026.
" data-astro-cid-igrglyo7>Based on a 4.18% 10Y Treasury yield, a 5.5% equity risk premium, and HCA's beta. Weighted average cost of capital incorporates their substantial debt load.
" data-astro-cid-igrglyo7>Assumed perpetual growth rate after year 5. Set at 2.5%, slightly below historical GDP growth, representing a mature, stable state.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 1.5% | $9.24 | $7.70 | $6.60 | $5.78 | $5.13 |
| 2.0% | $10.27 | $8.40 | $7.11 | $6.16 | $5.44 |
| 2.5% | $11.55 | $9.24 | $7.70 | $6.60 | $5.77 |
| 3.0% | $13.20 | $10.27 | $8.40 | $7.11 | $6.16 |
| 3.5% | $15.40 | $11.55 | $9.24 | $7.70 | $6.60 |
■ Undervalued vs current price ■ Overvalued vs current price
Westmount Research. "HCA Healthcare (HCA) Intrinsic Value: A DCF Analysis." westmountfundamentals.com, March 19, 2026.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.